MALAT1 and neoplasm: Significant differences in tumor volumes could be observed after 5 days and persisted until the experimental endpoint (Fig. 6a), at which point NC ASO injected tumors were much larger than those injected with MALAT1 ASO (n = 5; P = 0.00156) (Fig. 6b).